The applicant will take part in the project “Enteroprobe”, which is funded by the Région Rhône Alpes Auvergne, funded and granted to Pr. Donald Martin in partnership with the company Pelican Health SAS, and hosted in the TIMC laboratory of the University Grenoble Alpes.
Enteroprobe is a project supporting the development of a novel in-situ microbiome sampling medical device by Pelican Health SAS. The novel approach will give access to the small intestine, open a better understanding of the intestinal microbiome and its relationship with the host, and allow the development of new nutritional, therapeutic and diagnostic solutions. In this context, the postdoctoral applicant will setup an in-vitro platform for the development of the medical device and the study of the small intestinal microbiome and its evolution. He/she will select and develop culture media and conditions for mock microbiome communities and retrieved samples. The applicant will also perform metagenomics analysis to characterize the system.
The applicant should have
For more information / to apply, see:
Deadline for applications: 30/04/2021
Contract duration: 18 months, as soon as possible
Contacts: Pr Donald Martin - Don.Martin [at] univ-grenoble-alpes.fr
Candidates should send a brief statement of their research interests, their CV and at least two recommendation contacts.